Cellular toxicity of nicotinamide metabolites.
There are almost 100 different substances called uremic toxins. Nicotinamide derivatives are known as new family of uremic toxins. These uremic compounds play a role in an increased oxidative stress and disturbances in cellular repair processes by inhibiting poly (ADP-ribose) polymerase activity. New members of this family were discovered and described. Their toxic properties were a subject of recent studies. This study evaluated the concentration of 4-pyridone-3-carboxamid-1-β-ribonucleoside-triphosphate (4PYTP) and 4-pyridone-3-carboxamid-1-β-ribonucleoside-monophosphate (4PYMP) in erythrocytes of patients with chronic renal failure. Serum and red blood cells were collected from chronic renal failure patients on conservative treatment, those treated with hemodialysis, and at different times from those who underwent kidney transplantation. Healthy volunteers served as a control group. Nicotinamide metabolites were determined using liquid chromatography with mass spectrometry based on originally discovered and described method. Three novel compounds were described: 4-pyridone-3-carboxamid-1-β-ribonucleoside (4PYR), 4PYMP, and 4PYTP. 4PYR concentration was elevated in the serum, whereas 4PYMP and 4PYTP concentrations were augmented in erythrocytes of dialysis patients. Interestingly, concentrations of these compounds were less elevated during the treatment with erythropoietin-stimulating agents (ESAs). After successful kidney transplantation, concentrations of 4PYR and 4PYMP normalized according to the graft function, whereas that of 4PYTP was still elevated. During the incubation of erythrocytes in the presence of 4PYR, concentration of 4PYMP rose very rapidly while that of 4PYTP increased slowly. Therefore, we hypothesized that 4PYR, as a toxic compound, was actively absorbed by erythrocytes and metabolized to the 4PYMP and 4PYTP, which may interfere with function and life span of these cells.
Department of Nephrology, Transplantation and Internal Medicine, Medical University of Gdansk, Gdansk, Poland. bolo@gumed.edu.pl
Bolesław
B
Rutkowski
Przemysław
P
Rutkowski
Ewa
E
Słomińska
Ryszard T
RT
Smolenski
Julian
J
Swierczyński
D000042:Absorption; D000328:Adult; D002648:Child; D004912:Erythrocytes / Q000737:chemistry; D004921:Erythropoietin / Q000378:metabolism; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy; D016030:Kidney Transplantation; D009705:Nucleosides / Q000097:blood / Q000633:toxicity; D009711:Nucleotides / Q000097:blood* / Q000633:toxicity; D018384:Oxidative Stress; D011064:Poly Adenosine Diphosphate Ribose / Q000037:antagonists & inhibitors; D011728:Pyridones / Q000097:blood* / Q000633:toxicity; D006435:Renal Dialysis
C516364:4-pyridone-3-carboxamide N-1 riboside triphosphate; C554932:4-pyridone-3-carboxamide-1-ribonucleoside; C571870:4-pyridone-3-carboxamide-1-ribonucleoside monophosphate; D009705:Nucleosides; D009711:Nucleotides; D011728:Pyridones; D004921:Erythropoietin; D011064:Poly Adenosine Diphosphate Ribose